Targeting Bcl-xL enhances the cytotoxicity of chemotherapeutics.
Wang
Shulin
S
State Key Laboratory of Genetic Engineering, Institute of Genetics, Fudan University School of Life Sciences, Shanghai 200433, PR China. shulinwang@fudan.edu.cn
D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis; D004357:Drug Synergism; D006801:Humans; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000502:physiology; D051020:bcl-X Protein / Q000037:antagonists & inhibitors* / Q000502:physiology
D000970:Antineoplastic Agents; C494811:BCL2L1 protein, human; D019253:Proto-Oncogene Proteins c-bcl-2; D051020:bcl-X Protein